Progenika Gives Grifols Rights to Distribute Bloodchip | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Spanish biotech Progenika Biopharma has granted exclusive worldwide distribution rights to Grifols for its Bloodchip product line, Progenika announced today.

The chips are used for genotyping blood donors to assure compatibility between donor and recipient. Progenika and the Bloodgen Consortium, which consists of European blood banks and research institutes, developed the chips.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.